COVID-19: Molecular Research and Novel Therapy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 October 2025 | Viewed by 461
Special Issue Editor
Interests: immunology and immune response during viral infections; oncology; immunotherapy; intracellular signalling; targeted therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Since the COVID-19 pandemic, significant progress has been made in understanding the virus's pathogenic mechanisms, host–pathogen interactions, and the immunological responses that impact the disease’s outcome. These discoveries have boosted the development of antiviral drugs, vaccines, and diagnostic tools, offering improved possibilities in the fight against this global pandemic.
This Special Issue focuses on "COVID-19: Molecular Research and Novel Therapy", and welcomes original research articles, reviews, and short communications on the molecular mechanisms of SARS-CoV-2 infection, host immune responses, including innate and adaptive immunity, inflammation and immune evasion, development of antiviral agents, immunotherapies, and vaccines.
We look forward to receiving valuable contributions from the researchers all around the world, hoping to reveal cutting-edge knowledge that will contribute to the global effort to understand the pathogenesis of SARS-CoV-2, to reveal advancements in therapeutic interventions, and, at the same time, help the efforts to prevent and respond to other pandemics.
Dr. Mihaela Chivu-Economescu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2
- virus-host interaction
- immune response
- antiviral agents
- vaccines
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
